<img alt="" height="1" width="1" />Ironwood and Forest Announce Positive Linaclotide Results from Two Pivotal ...WELT ONLINELinaclotide, the Company's first-in-class compound, is being evaluated in a confirmatory Phase 3 program for the treatment of irritable bowel syndrome with ...Ironwood and Forest Announce Positive Linaclotide Results from Two Pivotal ...<nobr>istockAnalyst.com (press release)</nobr><nobr>all 14 news articles »</nobr> |